Working… Menu

A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03570931
Recruitment Status : Active, not recruiting
First Posted : June 27, 2018
Last Update Posted : October 14, 2021
Information provided by (Responsible Party):
Retrotope, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 9, 2020
Estimated Study Completion Date : June 30, 2022